Skip to main content
Equibles

Thomas (Tom) Pike

CEO

Labcorp Holdings Inc. (LH)

Chairman

Labcorp Holdings Inc. (LH)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Thomas (Tom) Pike

Thomas (Tom) Pike is recorded as CEO and Chairman at Labcorp Holdings Inc. (LH). Labcorp Holdings Inc. reported in an 8-K filed January 5, 2023 that Thomas (Tom) Pike was appointed chief executive officer and chairman of the Board of Directors of the spun-off company. Labcorp Holdings Inc. reported in an 8-K filed January 5, 2023 that Thomas (Tom) Pike was appointed president and chief executive officer of its Drug Development Clinical Development business unit, effective January 9, 2023.

“upon completion of the previously announced planned spin-off of Labcorp's Clinical Development business, Mr. Pike will become chief executive officer and chairman of the Board of Directors of the spun-off company.”
Labcorp Holdings Inc. Form 8-K, filed January 5, 2023 · Read the filing
“Thomas (Tom) Pike will join Labcorp as president and chief executive officer of its Drug Development Clinical Development business unit effective January 9, 2023”
Labcorp Holdings Inc. Form 8-K, filed January 5, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Labcorp Holdings Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.